相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Gregorio Tersalvi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events
Paul P. Dobesh et al.
CLINICAL THERAPEUTICS (2020)
The 'Ten Commandments' for the 2020 ESC Guidelines for themanagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2020)
Clopidogrel Pharmacogenetics State-of-the-Art Review and the TAILOR-PCI Study
Naveen L. Pereira et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
Yilong Wang et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Ticagrelor - toward more efficient platelet inhibition and beyond
Michal J. Kubisa et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease
Heyang Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events
Zaina T. Al-Salama et al.
DRUGS (2017)
Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia
Gian Marco Rosa et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Racial/Ethnic Differences in Drug Disposition and Response: Review of Recently Approved Drugs
A. Ramamoorthy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
An open-label, randomized bioavailability study with alternative methods of administration of crushed ticagrelor tablets in healthy volunteers
Renli Teng et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update
Jennifer N. Smith et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2015)
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Pontus Andell et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers
Renli Teng et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial
Kenneth W. Mahaffey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease
Y. Hiasa et al.
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2014)
Pharmacokinetics and Tolerability of Single and Multiple Doses of Ticagrelor in Healthy Chinese Subjects An Open-Label, Sequential, Two-Cohort, Single-Centre Study
Haiyan Li et al.
CLINICAL DRUG INVESTIGATION (2012)
Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals
Renli Teng et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Lack of significant food effect on the pharmacokinetics of ticagrelor in healthy volunteers
R. Teng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes
Yanushi Dullewe Wijeyeratne et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Ticagrelor A Review of its Use in the Management of Acute Coronary Syndromes
Emma D. Deeks
DRUGS (2011)
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study
Paul A. Gurbel et al.
CIRCULATION (2010)
Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome
M. Bebawy et al.
CURRENT DRUG METABOLISM (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
A Westlind-Johnsson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
分享论文
